This matter was addressed in the last telecon. Cash will see them through to end 2013. No plans to ramp up spending in 2013.
Next trigger for the SP will be confirmation from the FDA on what's required for approval. If its a simple rejig of existing data plus new data from the 022 study the SP will bounce.
reality check, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
